disorder

InfoWars – Barcelona Soccer Star Who Pushed Covid Vax On Kids Collapses On Field, Diagnosed With Heart Disorder

by Kelen McBreen

Source: https://www.infowars.com/posts/barcelona-soccer-star-who-pushed-covid-vax-on-kids-collapses-on-field-diagnosed-with-heart-disorder/

“The first team player Sergio Aguero reported chest discomfort and has been admitted to the hospital for a cardiac exam,” the team said in a statement following the game.

While Aguero’s vaccination status has yet to be confirmed, a Football Espana report from September claimed 99.99% of the team’s staff is vaccinated.

Early on in the Covid-19 pandemic, Aguero said he was anticipating the development of a vaccine “so that this all ends,” and in September he promoted the jab to 12-year-olds.

Vaccine News – Vaccine industry in panic as scientific study solves the riddle of why flu shots don’t work

Vaccine industry in panic as scientific study solves the riddle of why flu shots don’t work
Wednesday, November 01, 2017
The flu shot is a quack science medical hoax. While some vaccines do confer immunization effectiveness, the flu shot isn’t one of them. Recent studies, for example, have proven that flu shots sharply weaken immunity in subsequent years following immunization. In some years, the flu shot viral strains are completely wrong, offering no immunity at all to influenza strains circulating in the world. Even when flu shots are the “right” strain, flu vaccine insert sheets readily admit the shots have not been subjected to double blind placebo controlled studies, and there is no legitimate scientific evidence whatsoever that supports the claim that each year’s flu vaccine confers meaningful immunity.

The Ohio State University – Wexner medical center
Study Charts Flu Shot’s Impact on Pregnant Women and Their Babies
In all, researchers followed 141 pregnant women, 91 of whom received a flu shot in the previous year, 50 who had not. “We actually found that those who didn’t get a flu shot had a better initial immune response to the vaccine,” said Christian. “On the other hand, for those who tend to get flu shots year after year, their peak antibody response becomes weakened over time.”

Study – A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States

US National Library of Medicine
National Institutes of Health – Dec 2013

David A Geier,1 Brian S Hooker,2 Janet K Kern,1,3 Paul G King,4 Lisa K Sykes,4 and Mark R Geiercorresponding author1
1 The Institute of Chronic Illnesses Inc, 14 Redgate Ct, Silver Spring, MD, USA
2 Simpson University, Redding, CA, USA
3 University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA
4 CoMeD Inc, Silver Spring, MD, USA
corresponding authorCorresponding author.
David A Geier: ten.tsacmoc@reiegnelladivad; Brian S Hooker: ude.unospmis@rekoohb; Janet K Kern: ten.riawfd@nrekj; Paul G King: moc.liamg@dhpgnikgluap; Lisa K Sykes: ten.nozrev@5enolkys; Mark R Geier: ten.tsacmoc@reiegm

Abstract

Background
Autism spectrum disorder (ASD) is defined by standardized criteria of qualitative impairments in social interaction, qualitative impairments in communication, and restricted and stereotyped patterns of behavior, interests, and activities. A significant number of children diagnosed with ASD suffer a loss of previously-acquired skills, which is suggestive of neurodegeneration or a type of progressive encephalopathy with an etiological pathogenic basis occurring after birth. To date, the etiology of ASD remains under debate, however, many studies suggest toxicity, especially from mercury (Hg), in individuals diagnosed with an ASD. The present study evaluated concerns about the toxic effects of organic-Hg exposure from Thimerosal (49.55% Hg by weight) in childhood vaccines by conducting a two-phased (hypothesis generating/hypothesis testing) study with documented exposure to varying levels of Thimerosal from vaccinations.

Methods
A hypothesis generating cohort study was undertaken to evaluate the relationship between exposure to organic-Hg from a Thimerosal-containing Diphtheria-Tetanus-acellular-Pertussis (DTaP) vaccine in comparison to a Thimerosal-free DTaP vaccine administered, from 1998 through 2000, for the risk of ASD as reported in the Vaccine Adverse Event Reporting System (VAERS) database (phase I). A hypothesis testing case–control study was undertaken to evaluate the relationship between organic-Hg exposure from Thimerosal-containing hepatitis B vaccines administered at specific intervals in the first six months of life among cases diagnosed with an ASD and controls born between 1991 through 1999 in the Vaccine Safety Datalink (VSD) database (phase II).

Results
In phase I, it was observed that there was a significantly increased risk ratio for the incidence of ASD reported following the Thimerosal-containing DTaP vaccine in comparison to the Thimerosal-free DTaP vaccine. In phase II, it was observed that cases diagnosed with an ASD were significantly more likely than controls to receive increased organic-Hg from Thimerosal-containing hepatitis B vaccine administered within the first, second, and sixth month of life.

Conclusions
Routine childhood vaccination is an important public health tool to reduce the morbidity and mortality associated with infectious diseases, but the present study provides new epidemiological evidence supporting an association between increasing organic-Hg exposure from Thimerosal-containing childhood vaccines and the subsequent risk of an ASD diagnosis.

Study – Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women.

Authors
Zheteyeva YA1, Moro PL, Tepper NK, Rasmussen SA, Barash FE, Revzina NV, Kissin D, Lewis PW, Yue X, Haber P, Tokars JI, Vellozzi C, Broder KR.
Author information
1 Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA, USA.

Abstract

OBJECTIVE: We sought to characterize reports to the Vaccine Adverse Event Reporting System (VAERS) of pregnant women who received tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap).

STUDY DESIGN: We searched VAERS for reports of pregnant women who received Tdap from Jan. 1, 2005, through June 30, 2010. We conducted a clinical review of reports and available medical records.

RESULTS: We identified 132 reports of Tdap administered to pregnant women; 55 (42%) described no adverse event (AE). No maternal or infant deaths were reported. The most frequent pregnancy-specific AE was spontaneous abortion in 22 (16.7%) reports. Injection site reactions were the most frequent non-pregnancy-specific AE found in 6 (4.5%) reports. One report with a major congenital anomaly (gastroschisis) was identified.

CONCLUSION: During a time when Tdap was not routinely recommended in pregnancy, review of reports to VAERS in pregnant women after Tdap did not identify any concerning patterns in maternal, infant, or fetal outcomes.

VAXXED TV – Doctors are all singing from the same hymn sheet
Mother shares her frustrations with the medical industry in trying to deal with her child’s vaccine injuries.
interview recorded on April 29th, 2017 in The United Kingdom Edited by TJ Jones

He was seizing over and over and over
Mother shares story of events of her son and his vaccine reactions.
interview recorded on April 29th, 2017 in The United Kingdom Edited by TJ Jones

All 3 of children are injured from vaccines

Vaccines gave my son autism

My grandson has autism from vaccines

Unvaccinated

My daughter has autism from vaccines

Flu vaccine killed my daughter

My daughter has diabetes from vaccines

Vaccines killed my baby boy

****************************************************

How to accept Jesus Christ as your personal Saviour

Testimony by Phil Robertson from Duck Dynasty

1 Corinthians 15 Authorized (King James) Version (AKJV)
1 Moreover, brethren, I declare unto you the gospel which I preached unto you, which also ye have received, and wherein ye stand;
2 by which also ye are saved, if ye keep in memory what I preached unto you, unless ye have believed in vain.
3 For I delivered unto you first of all that which I also received, how that Christ died for our sins according to the scriptures;
4 and that he was buried, and that he rose again the third day according to the scriptures:

Hebrews 6 Authorized (King James) Version (AKJV)
1 Therefore leaving the principles of the doctrine of Christ, let us go on unto perfection; not laying again the foundation of repentance from dead works, and of faith toward God,
2 of the doctrine of baptisms, and of laying on of hands, and of resurrection of the dead, and of eternal judgment.
3 And this will we do, if God permit.
4 For it is impossible for those who were once enlightened, and have tasted of the heavenly gift, and were made partakers of the Holy Ghost,
5 and have tasted the good word of God, and the powers of the world to come,
6 if they shall fall away, to renew them again unto repentance; seeing they crucify to themselves the Son of God afresh, and put him to an open shame.
7 For the earth which drinketh in the rain that cometh oft upon it, and bringeth forth herbs meet for them by whom it is dressed, receiveth blessing from God:
8 but that which beareth thorns and briers is rejected, and is nigh unto cursing; whose end is to be burned.

Vaccine News – Study – Gender-selective toxicity of thimerosal

PubMed.gov – Mar.2009
Abstract
A recent report shows a correlation of the historical use of thimerosal in therapeutic immunizations with the subsequent development of autism; however, this association remains controversial. Autism occurs approximately four times more frequently in males compared to females; thus, studies of thimerosal toxicity should take into consideration gender-selective effects. The present study was originally undertaken to determine the maximum tolerated dose (MTD) of thimersosal in male and female CD1 mice. However, during the limited MTD studies, it became apparent that thimerosal has a differential MTD that depends on whether the mouse is male or female. At doses of 38.4-76.8mg/kg using 10% DMSO as diluent, seven of seven male mice compared to zero of seven female mice tested succumbed to thimerosal. Although the thimerosal levels used were very high, as we were originally only trying to determine MTD, it was completely unexpected to observe a difference of the MTD between male and female mice. Thus, our studies, although not directly addressing the controversy surrounding thimerosal and autism, and still preliminary due to small numbers of mice examined, provide, nevertheless, the first report of gender-selective toxicity of thimerosal and indicate that any future studies of thimerosal toxicity should take into consideration gender-specific differences.
PubMed.gov – 15.Mar.2010
Abstract
Mercury (Hg) exposure from dental amalgam fillings and thimerosal in vaccines is not a major health hazard, but adverse health effects cannot be ruled out in a small and more susceptible part of the exposed population. Individual differences in toxicokinetics may explain susceptibility to mercury. Inbred, H-2-congenic A.SW and B10.S mice and their F1- and F2-hybrids were given HgCl2 with 2.0 mg Hg/L drinking water and traces of (203)Hg. Whole-body retention (WBR) was monitored until steady state after 5 weeks, when the organ Hg content was assessed. Despite similar Hg intake, A.SW males attained a 20-30% significantly higher WBR and 2- to 5-fold higher total renal Hg retention/concentration than A.SW females and B10.S mice. A selective renal Hg accumulation but of lower magnitude was seen also in B10.S males compared with females. Differences in WBR and organ Hg accumulation are therefore regulated by non-H-2 genes and gender. Lymph nodes lacked the strain- and gender-dependent Hg accumulation profile of kidney, liver and spleen. After 15 days without Hg A.SW mice showed a 4-fold higher WBR and liver Hg concentration, but 11-fold higher renal Hg concentration, showing the key role for the kidneys in explaining the slower Hg elimination in A.SW mice. The trait causing higher mercury accumulation was not dominantly inherited in the F1 hybrids. F2 mice showed a large inter-individual variation in Hg accumulation, showing that multiple genetic factors influence the Hg toxicokinetics in the mouse. The genetically heterogeneous human population may therefore show a large variation in mercury toxicokinetics.
US National Library of Medicine – National Institutes of Health – Feb.2015
Results
Developmental Domain: ASD Diagnostic Criteria
Social Communication/Social Interaction
Deficits in social communication and social interaction are core factors in the diagnostic criteria of ASD. Impairments in social communication may present as abnormalities in eye contact, poor integration of verbal and nonverbal behaviors, and difficulties understanding the nonverbal communication of others (American Psychiatric Association, 2013). In some cases, persons with ASD may not participate in conversation or struggle with pragmatic language (American Psychiatric Association, 2013). Impairments in social interaction include difficulties with social-emotional reciprocity, failure to develop peer relationships, and reduced empathetic understanding and/or response (American Psychiatric Association, 2013).
There were 21 articles reviewed on social communication and social interaction in persons with ASD published between 1993 and 2013: 13 case-control studies, 7 cross-sectional studies, and 1 surveillance study. Nine studies were conducted in the United States and 12 studies were conducted at outside of the US. Of these 21 articles, 14 address social communication or other language abilities. In samples of children with varying cognitive abilities, some studies showed no significant differences in communication, conversational deficits, and language levels between males and females with ASD (Andersson et al., 2013; Dawson et al., 2007; Nicholas et al., 2008; Pilowsky et al., 1998; Park et al., 2012a, 2012b; Mayes and Calhoun, 2011; Mandy et al., 2012; Sipes et al., 2011; Solomon et al., 2012; Amr et al., 2011). One study found that males with ASD had greater expressive and receptive language skills than females with ASD (Carter et al., 2007) and another study found that females with ASD had more impaired social communication skills than males with ASD (Hartley and Sikora, 2009). Conversely, Park et al. (2012b) found that females with ASD had stronger non-verbal communication abilities than males with ASD. The majority of the literature reviewed on social communication found no difference between males and females with ASD, but there is some inconsistency.
The literature on sex differences in social interaction among persons with ASD (13 of 21 articles reviewed) is also inconsistent but generally suggests no significant sex differences in social interaction skills (Andersson et al., 2013; Dawson et al., 2007; Nicholas et al., 2008; Pilowsky et al., 1998; Mayes and Calhoun, 2011; Park et al. 2012b; Mandy et al., 2012; Sipes et al., 2011; Solomon et al., 2012). In population-level surveillance of eight-year olds, 80 % of children with ASD had poor social-emotional reciprocity with no significant difference between males and females (Nicholas et al., 2008). Szatmari et al. (2012) also found no sex differences in social-emotional reciprocity for children with varying cognitive abilities in a study from the Autism Genome Project. Oppositely, in an age and IQ matched case–control study, female adults with ASD were found to have fewer socio-communication difficulties during interpersonal interaction than male adults with ASD (Lai et al., 2013). Lastly, no sex differences have been noted in emotional reactiveness or being withdrawn (Hartley and Sikora, 2009) and in empathetic understanding and responses (Auyeung et al., 2009).
Cognitive functioning is likely to play a role in these social processes. Lower intellectual abilities are often linked with greater social impairment regardless of sex (Dawson et al., 2007). Among children with high functioning autism (IQ≥70), social skills have been found to be more impaired in female children than male children (Holtmann et al., 2007) and more severe as children aged (McLennan et al., 1993). In contrast, other studies found adult females with high functioning autism to have less socio-communication issues compared to males (Lai et al., 2011) or there were no sex differences in socio-communication skills in older children and adolescents (Holtmann et al., 2007; Kopp and Gillberg, 2011).
Overall, the 21 articles reviewed suggest no difference in social interaction between males and females with ASD and inconsistent differences in social communication between males and females with ASD, although both social interaction and social communication may be influenced by intellectual ability and age.
Restricted, Repetitive Patterns of Behavior, Interests, or Activities
There were 18 articles reviewed on restricted and repetitive patterns of behaviors and interests (RRBI) published between 1993 and 2013: nine cross-sectional studies, seven case–control studies, one cohort study, and one surveillance study. Eleven studies were conducted in the United States and seven studies were conducted in other countries. Based on this review, the literature suggests that males with ASD have more RRBI than females with ASD (Hattier et al., 2011; Carter et al., 2007). When assessing individual facets of RRBI, restricted interests are seen more often in males with ASD than females with ASD independent of cognitive ability (Kohane et al., 2012; May et al., 2012; Mandy et al., 2012; Szatmari et al., 2012). Males with ASD are also more likely to have more routines, rituals, and fascination with parts of objects than females with ASD (Nicholas et al., 2008; Park, et al., 2012b; Beuker et al., 2013). The literature on repetitive motor movements is less consistent: adult males with high functioning autism or Asperger’s syndrome had more repetitive motor movements than adult females with high functioning autism or Asperger’s syndrome in one case-control study (May et al., 2012), but there were no sex differences in repetitive motor movements among persons with autism in two other case-control studies (McLennan et al., 1993; Worley and Matson, 2011), one cross-sectional study (Auyeung et al., 2009), and one population-based cross-sectional study (Nicholas et al., 2008).
Age may influence the presentation of RRBI in males and females with ASD. One study found no sex difference among RRBI in toddlers (Sipes et al., 2011), whereas a different study found significantly more RRBI among adult males with ASD compared to females with ASD (Hattier et al., 2011). In summation, most studies reviewed suggested that males with ASD are likely to have more RRBI than females with ASD across levels of cognitive ability, although RRBI may be influenced by age.
Sensory issues are prevalent among persons with ASD (Nicholas et al., 2008) and are included as a RRBI in the DSM 5 (American Psychiatric Association, 2013). Common issues are oversensitivity to touch, sound, smell, taste, and attraction to certain tactile stimuli (American Psychiatric Association, 2013; Baranek et al., 2006; Rogers et al., 2003). Abnormal sensory reactions have been reported to occur in up to 47 % of persons with ASD, which is a rate ten times higher than reported in the general population (Nicholas et al., 2008). Additionally, there is a significant correlation between sensory issues in each of the individual senses (Kern et al., 2007); therefore, impairment is compounded for persons with ASD and sensory abnormalities.
Cross-sectional studies found no observed differences between males and females in sensitivity to sound (Mandy et al., 2012) or sensory sensitivity in general (Louisa et al., 2012; Mayes and Calhoun, 2011; Baranek et al., 2006). Mandy et al. (2012) examined RRBI in children and adolescents 3 to 18 years of age and found that age did not influence the presentation of RRBI. However, Lai et al. (2011) found that adult females with high functioning autism had more lifetime sensory issues than males with ASD. Overall, the majority of articles reviewed that addressed sensory issues in ASD do not suggest a sex difference, although aging may be a factor and should be further explored.
Developmental Domain: other Developmental Endophenotypes
Attention Deficit Hyperactivity Disorder
Attention deficit hyperactivity disorder (ADHD) and corresponding symptoms are common in children with ASD (Bradley and Isaacs, 2006; Nicholas et al., 2008). Previous studies show that 50 % to 83 % of children and teenagers with ASD had hyperactivity and attention problems (Nicholas et al., 2008; Bradley and Isaacs, 2006). There were seven articles that met search criteria and addressed ADHD. These seven articles were published between 2008 and 2012 with five cross-sectional studies and two cohort studies. Two studies were conducted in the United States and five were conducted in other countries.
A study of 7 to 12 year-olds with varying cognitive abilities found that males with ASD had higher levels of hyperactivity and impulsivity than females with ASD and this difference was more pronounced at younger ages (May et al., 2012). Males with high functioning autism from middle childhood to adolescence had higher levels of hyper-activity and inattention in teacher reports as compared to female peers, but there was no difference in parental reports (Mandy et al., 2012). A study of children and young adults aged 5 to 20 with high functioning autism found females had more attention problems (Bryson et al., 2008). A majority of studies found no difference in ADHD co-occurrence between males and females with ASD (Simonoff et al., 2008; Sinzig et al., 2009; Mayes and Calhoun, 2011; Horovitz et al., 2011). In summary, the current literature leans toward no sex differences in the co-occurrence of ADHD and ASD, but there is still inconsistency in the literature and thus, the sex difference is largely inconclusive
Challenging Behavior (Aggressiveness/Temper Tantrums/Oppositional Tendencies)
Challenging behavior is a common associated feature of ASD and includes aggression expressed toward other people, temper tantrums, and oppositional and defiant tendencies. Aggression expressed toward other people and temper tantrums are found in 50 % and 54 % of children with ASD compared to only 28 % and 23 % of children without ASD (Nicholas et al., 2008). The 12 articles in this review that met search criteria and addressed challenging behaviors were published between 2005 and 2012 and included six cross-sectional studies, four case–control studies, one clinical trial, and one surveillance study. Six studies were conducted in the United States and six were conducted in other countries. In general, there were no differences in aggression, temper tantrums, or anger between child sexes, regardless of age or cognitive ability (Kozlowski et al., 2012; Worley and Matson, 2011; Carter et al., 2007; Murphy et al., 2009; Mandy et al., 2012; Quek et al., 2012; Mayes and Calhoun, 2011; Horovitz et al., 2011). One study found that females with ASD had more “challenging behaviors” than males with ASD, although challenging behaviors were not explicitly defined (Dworzynski et al., 2012). Delinquent behavior (Park et al., 2012b) and oppositional defiance (Gadow et al., 2005) were more prevalent in males than in females with ASD in two studies reviewed.
Cognitive Skills and Intellectual Disability
In a review from 1966 to 2001, Fombonne (2003) found that the median prevalence of intellectual impairment in persons with ASD was 70 % in the studies evaluated. More recent population-based studies have found lower rates of ID in persons with ASD, with a range from 18 % to 55 % (Charman et al., 2011). The National Health Interview Study found 0.71 % of all children aged 3 to 17 from 1998 to 2007 had an ID (Boyle et al., 2011). Our review found 12 articles that met the search criteria and addressed ID or specific cognitive skills. These 12 articles were published between 1983 and 2011, and included seven cross-sectional studies, four case–control studies, and one-surveillance study. Four studies were conducted in the United States and eight were conducted in other countries.
The 12 articles reviewed support a relationship between child sex and co-occurring ID in children with ASD. The sex ratio between males and females without ID is greater than the sex ratio for all levels of cognitive ability combined (Nicholas et al., 2008; Hartley and Sikora, 2009). Consequently, the male to female ratio is lower when there is co-occurring ID compared to when there is no co-occurring ID (Hartley and Sikora, 2009; Nicholas et al., 2008; Yeargin-Allsopp et al., 2003). The ratio of males to females with ASD and co-occurring ID has been seen to range from 1.3:1 (Tsai and Beisler, 1983) to 2.8:1 (Bryson et al., 2008) with a trend toward fewer sex differences as ID becomes more severe (Yeargin-Allsopp et al., 2003). This differential sex difference in ID results in females with ASD, on average, having lower intelligence test scores than males with ASD (Banach et al., 2009; Volkmar et al., 1993).
Specific cognitive skills posited to vary between males and females with ASD include cognitive flexibility, response inhibition, working memory, and attention to detail (Geurts et al., 2004). Female adolescents with high functioning autism were seen to have superior information processing, multiple conceptual tracking, divided attention, and cognitive flexibility compared to male adolescents with high functioning autism (Bolte et al., 2011). In contrast, studies show males with ASD have superior attention to detail, visuo-spatial skills (Auyeung et al., 2009), and inhibitory control (Lemon et al., 2011) compared to females with ASD. There were no sex differences between adults with ASD in the “eyes test” which measures ability to infer mental states through the eyes (Lai et al., 2011). In summary, the 12 journal articles reviewed in this section suggest that females with ASD generally have lower intelligence test scores than males with ASD and that specific cognitive skills may vary by sex.
Developmental Regression
Parents of some children with ASD report a period of typical development followed by a loss in language, social, motor, self-help, imaginative play, or other skills. This developmental regression is usually reported to occur between 15 and 24 months of age (Meilleur and Fombonne, 2009). Our review found six articles that met search criteria and addressed developmental regression. These six articles were published between 2007 and 2013 and comprised two cohort studies, three cross-sectional studies, and one surveillance study. In a population-based surveillance study of children with ASD, 17 % of children had documented developmental regression and that percentage rose if the child had a previous ASD diagnosis (Wiggins et al., 2009). Males had significantly more regression than females and were more likely to regress at a younger age (Wiggins et al., 2009). This higher risk of regression in males was also seen in smaller, non-population based studies (n=4, 8, and 17 female children) (Bernabei et al., 2007; Ekinci et al., 2012; Zhang et al., 2012). In contrast, a cross-sectional study found that females aged 18 months to 15 years had significantly higher occurrence of regression as compared to males (30 % vs. 19 %) (Ben-Itzchak et al., 2013). No difference in the presence of developmental regression between males and females with ASD was observed in a small clinical sample of 20 females (Meilleur and Fombonne, 2009). In sum, the review of sex differences of developmental regression is contradictory and thus inconclusive.
Excess/Absence of Fear
Excess or absence of fear is more common in children with ASD than other children (Evans et al. 2005; Nicholas et al., 2008). In a population-based surveillance of eight-year olds, Nicholas et al. (2008) found that 32 % of children with ASD had atypical fear noted in service records compared to 6 % of children with ASD symptoms but no ASD diagnosis. Three articles met search criteria and addressed excess or absence of fear. All three of these articles were published in the United States between 1990 and 2011 and were two cross-sectional studies and one case–control study. In these studies, females with ASD had more specific phobias than males with ASD (Gadow and DeVincent, 2012; Matson and Love, 1990) and more unusual fears (Mayes et al., 2013). One study conducted by Matson and Love (1990) found more fear in typically developing female children compared to male children and no significant difference in fear between typically developing female children and female children with ASD. Given the sparse amount of research on this topic, further exploration is warranted to understand sex differences in fear among persons with ASD.
Safety Issues (Self-Injury/Elopement)
About 50 % of children with ASD engage in self-injurious behavior (Richards et al., 2012; Baghdadli et al., 2003; Duerden et al., 2012). Four studies met search criteria and three pertained to self-injurious behavior. All three of these studies were cross-sectional designs with two being conducted in Europe and one in the United States. No difference in self-injurious behavior was found between males and females with ASD (Richards et al., 2012; Baghdadli et al., 2003; Duerden et al., 2012).
Elopement, also known as wandering off, is a rising concern among parents of children with ASD. One online survey addressing elopement met our search criteria. This survey was conducted in the United States in 2013 and found that 49 % of parents reported that their child with an ASD wandered off at least once after the age of four years (Anderson et al., 2012). Results also found that sex did not influence the prevalence of elopement, although children with more intellectual impairment were more likely to elope (Anderson et al., 2012). Few conclusions can be drawn since there is little research on elopement and other safety issues in children with ASD and associated sex differences.
Psychiatric Domain
Anxiety/Mood Disorders
Symptoms of anxiety and mood disorders are more prevalent in children with ASD than in typically developing children (Worley and Matson, 2011; Nicholas et al., 2008). Among children who met a surveillance definition for an ASD, 55 % had abnormal mood or affect compared to 26 % of children with at least one symptom of an ASD but no ASD diagnosis (Schendel et al., 2009). The Special Needs Autism Project in the UK found 44 cases of emotional disorder per 100 children with ASD (Simonoff et al., 2008). Moreover, among eight-year-old children who met a surveillance definition for an ASD, 3 % had anxiety, 2 % had emotional disorder, 2 % had mood disorder, and less than 2 % had obsessive-compulsive disorder (OCD), depression, bipolar, or oppositional defiant disorder (Levy et al., 2010). Nine studies were found that met search criteria and addressed anxiety or mood disorders. These nine studies were published between 2005 and 2012 and included five cross-sectional studies and four case–control studies. Four of the studies were conducted in the United States and five were conducted in other countries.
The literature on sex differences in co-occurring anxiety or mood disorders and ASD is mixed and dependent on cognitive abilities. In some studies, females with high functioning autism were at greater risk for internalizing psychopathology than both male children with ASD and typically developing female children (Solomon et al., 2012; Mandy et al., 2012). These studies are supported by a Finnish report that found female children with ASD had lower scores on a test associated with major depressive disorder compared to male children with ASD (Mattila et al., 2010). Other studies found no sex differences in the of co-occurrence of anxiety or depression in children with ASD and varying cognitive abilities (Quek et al., 2012; Gadow et al., 2005; Park et al., 2012b; Simonoff et al., 2008; Mayes and Calhoun, 2011; Lai et al., 2011). In the general population, females have more panic attacks, generalized anxiety disorders and males have more social anxiety (American Psychiatric Association, 2013). Based on this review, the current literature is inconclusive on whether a sex difference in children with ASD and co-occurring anxiety or mood disorders exists, although a few studies suggest more anxiety and mood disorders in females than males with ASD.
Schizophrenia
Schizophrenia is a mental disorder that involves delusions, disorganized behavior, disorganized speech, hallucinations, and restrictions in the range and intensity of emotions (American Psychiatric Association, 2013). Schizophrenia typically presents between 18 and 30 years of age with earlier onset associated with male sex. Lifetime prevalence of schizophrenia is near 0.2 % (American Psychiatric Association, 2013) The prevalence of schizophrenia in eight-year olds with ASD is less than 1 % (Levy et al., 2010). Two articles met search criteria and addressed schizophrenia. These two articles were published in 2005 and 2010 and were both case–control studies. Review of the two studies found conflicting results on sex differences and the co-occurrence of ASD and schizophrenia or schizophrenia spectrum traits. A parental survey of 6 to 12 year olds with ASD found schizophrenia spectrum traits to be twice as prevalent in females compared to males (57 %: 28 %) independent of ID (Gadow and DeVincent, 2012). Conversely, in a group of 6 to 12 year olds with ASD and ID, schizophrenia was more common in males than females (Tsakanikos et al., 2011). Again, the literature is relatively sparse due to the late onset of schizophrenia and the rarity of co-occurring schizophrenia: future research is warranted.
Medical Domain
Birth defects/Chromosomal Disorders /Genetic Disorders
Population-based surveillance data from the 2008 ADDM report found that among children with ASD, less than 1 % had a co-occurrence of fragile X syndrome, Down syndrome, chromosomal disorders, or other genetic and congenital diagnoses (Levy et al., 2010). It is likely that these rates are under-reported because investigation of ASD co-occurring conditions was not the focus of the ADDM surveillance effort. However, a cohort study of children in Georgia found a similar prevalence of chromosomal disorders and Down syndrome in persons with ASD (Schendel et al., 2009).
There were four studies reviewed that met search criteria and addressed ASD sex differences in birth defects, chromosomal disorders, and genetic disorders: two systematic reviews, one case–control study, and one surveillance study. Co-occurring birth defects, such as impairments to the central nervous system, cardiovascular system, genitourinary system, or musculoskeletal system, appear more often in males than females with ASD. Among children with ASD, the male to female ratio was 9:1 if a child had a co-occurring birth defect and 3.6:1 if the child did not have a co-occurring birth defect (Schendel et al., 2009).
A review conducted by Reilly (2009) found that males with ASD have more co-occurring Down syndrome than females with ASD and the male to female ratio among children with both ASD and Down syndrome may be near the overall ASD prevalence ratio of 4:1. A review conducted by Wiznitzer (2004) found no difference between males and females with ASD and the co-occurrence of tuberous sclerosis. Clifford et al. (2007) found that about 70 % of males aged 5 to 80 with fragile X syndrome had co-occurring ASD while 23 % of females in the same age range with fragile X had co-occurring ASD. The difference in co-occurrence of ASD between males and females may suggest a greater association between the two conditions in males as compared to females.
It is important to note that birth defects, chromosomal disorders, and genetic disorders are rare and seldom studied. Therefore, the results on sex differences for co-occurring ASD and chromosomal and genetic conditions are inconclusive.
Head Size / Encephalopathy
Head size, specifically an enlarged head circumference or macrocephaly, has been associated with ASD (Wallace and Treffert, 2004). Three articles were reviewed that examined differences in head size between males and females with ASD. Studies include two case–control studies and one cross-sectional study. Two studies were conducted in the US and one study was conducted in Italy. A cross-sectional study by Fombonne et al. (1999) found no difference in head size between males and females aged 2 to 16 with ASD. Sacco et al. (2007) also found no difference in head size between males and females aged 3 to 16 with ASD. In contrast, Aylward et al. (2002) found larger head sizes in male adults and children compared to female adults and children with ASD, but the female sample size was low (n=9).
Abnormal Eating and Gastrointestinal Issues
In a population-based study conducted by Nicholas et al. (2008), about 54 % of children with ASD had an abnormality in eating, drinking, or sleeping, which is nearly 40 % higher than that of children with at least one symptom of ASD but no diagnosis (Nicholas et al., 2008). Some studies have shown an increase in certain gastrointestinal symptoms among persons with ASD, including constipation (Ibrahim et al., 2009) and diarrhea (Wang et al., 2006), while other studies found no significant increase in overall gastrointestinal symptoms or symptoms such as esophageal reflux, vomiting, and abdominal discomfort (Ibrahim et al., 2009; Wang et al., 2006; Valicenti-McDermott et al., 2007). However, little research on gastrointestinal issues has been conducted at a population level and no studies were found that compared males to females on gastrointestinal response. More research is needed to determine if there is an association between gastrointestinal symptoms and ASD and whether the association differs between the sexes.
Four studies were found that compared the sexes and addressed food selectivity. These four studies were conducted in the United States between 2006 and 2010 and included one case–control and three cross-sectional designs. In general, review of these studies found food selectivity and feeding issues to be more frequent in children with ASD than children without ASD (Valicenti-McDermott et al., 2007; Ibrahim et al., 2009), although limited research is available in this area. There was no difference between child sexes in over or under-eating in a study of children with high functioning autism (Worley and Matson, 2011) and no differences between the sexes in eating abnormalities in two studies conducted in children with ASD and varying cognitive abilities (Mayes and Calhoun, 2011; Horovitz et al., 2011). Based on this limited review, it appears unlikely that there is a difference in eating habits between males and females with ASD.
Seizures/ Epilepsy
Epilepsy and other seizure disorders co-occur in 5 % to 40 % of children with ASD and there is differential prevalence based on ID (Baird et al., 2008; Nicholas et al., 2008). This review found three articles that met search criteria and addressed seizures or epilepsy. These three articles were published between 2008 and 2013 and consist of a cohort study, one cross-sectional study, and one meta-analysis. Females with ASD were found to have more epilepsy than males with ASD; the male to female ratio drops to near 2:1 in children with ASD and co-occurring epilepsy, but this may be partly due to differential ID (Amiet et al., 2008; Bolton et al., 2011; Ben-Itzchak et al., 2013). There may be an increased likeliness in females with ASD to have co-occurring epilepsy or seizure disorder; however, the literature is sparse so a conclusion cannot be drawn. Further research is needed to enhance current knowledge of sex differences in children with ASD and epilepsy or seizure disorder.
Sleep Disturbances
In a systematic review of parental sleep surveys, sleep problems were present in 50 % to 80 % of children with ASD compared to 9 % to 50 % in matched typically developing children (Kotagal and Broomall, 2012). There were six articles reviewed that met search criteria and addressed sleep disturbances. These six articles were published between 2004 and 2012 and included two case–control studies, two cohort studies, and two cross-sectional studies. Four were conducted in the United States and three were conducted in other countries. Based on this review, some studies found no sex differences in sleep problems among persons with ASD (Liu et al., 2006; Wiggs and Stores, 2004; Mayes and Calhoun, 2011; Horovitz et al., 2011), one study found that female children with ASD have less sleep problems than male children with ASD (Sivertsen et al., 2012), and one study found female children with ASD have more sleep problems than male children with ASD (Hartley and Sikora, 2009). The minimal amount of research in this area leads to inconsistent results and prevents definitive conclusions on whether a sex difference exists in sleep disturbance.

Vaccine News – Associations of prenatal and early childhood mercury exposure with autistic behaviors at 5 years of age: The Mothers and Children’s Environmental Health (MOCEH) study

Science of The Total Environment – 2017
Highlights
•We explored the associations between blood mercury levels and autistic behaviors.
•This study involved an ongoing multi-center prospective birth cohort.
•Blood mercury levels were repeatedly measured from early pregnancy to 3 years.
•Autistic behaviors were assessed at 5 years with the Social Responsiveness Scale.
•Prenatal and early childhood mercury levels were associated with autistic behaviors.
Abstract
Background
Although mercury is an established neurotoxin, only few longitudinal studies have investigated the association between prenatal and early childhood mercury exposure and autistic behaviors.
Methods
We conducted a longitudinal cohort study using an ongoing prospective birth cohort initiated in 2006, wherein blood mercury levels were measured at early and late pregnancy; in cord blood; and at 2 and 3 years of age. We analyzed 458 mother-child pairs. Autistic behaviors were assessed using the Social Responsiveness Scale (SRS) at 5 years of age. Both continuous SRS T-scores and T-scores dichotomized by a score of ≥ 60 or < 60 were used as outcomes.
Results
The geometric mean of mercury concentrations in cord blood was 5.52 μg/L. In adjusted models, a doubling of blood mercury levels at late pregnancy (β = 1.84, 95% confidence interval [CI]: 0.39, 3.29), in cord blood (β = 2.24, 95% CI: 0.22, 4.27), and at 2 years (β = 2.12, 95% CI: 0.54, 3.70) and 3 years (β = 2.80, 95% CI: 0.89, 4.72) of age was positively associated with the SRS T-scores. When the SRS T-scores were dichotomized, we observed positive associations with mercury levels at late pregnancy (relative risk [RR] = 1.31, 95% CI: 1.08, 1.60) and in cord blood (RR = 1.28, 95% CI: 1.01, 1.63).
Conclusion
We found that blood mercury levels at late pregnancy and early childhood were associated with more autistic behaviors in children at 5 years of age. Further study on the long-term effects of mercury exposure is recommended.
Molecular Neurobiology – 22 July 2017
Abstract
Exposure to organic forms of mercury has the theoretical capacity to generate a range of immune abnormalities coupled with chronic nitro-oxidative stress seen in children with autism spectrum disorder (ASD). The paper discusses possible mechanisms explaining the neurotoxic effects of mercury and possible associations between mercury exposure and ASD subtypes. Environmental mercury is neurotoxic at doses well below the current reference levels considered to be safe, with evidence of neurotoxicity in children exposed to environmental sources including fish consumption and ethylmercury-containing vaccines. Possible neurotoxic mechanisms of mercury include direct effects on sulfhydryl groups, pericytes and cerebral endothelial cells, accumulation within astrocytes, microglial activation, induction of chronic oxidative stress, activation of immune-inflammatory pathways and impairment of mitochondrial functioning. (Epi-)genetic factors which may increase susceptibility to the toxic effects of mercury in ASD include the following: a greater propensity of males to the long-term neurotoxic effects of postnatal exposure and genetic polymorphisms in glutathione transferases and other glutathione-related genes and in selenoproteins. Furthermore, immune and inflammatory responses to immunisations with mercury-containing adjuvants are strongly influenced by polymorphisms in the human leukocyte antigen (HLA) region and by genes encoding effector proteins such as cytokines and pattern recognition receptors. Some epidemiological studies investigating a possible relationship between high environmental exposure to methylmercury and impaired neurodevelopment have reported a positive dose-dependent effect. Retrospective studies, on the other hand, reported no relationship between a range of ethylmercury-containing vaccines and chronic neuropathology or ASD. On the basis of these results, we would argue that more clinically relevant research is required to examine whether environmental mercury is associated with ASD or subtypes. Specific recommendations for future research are discussed.
PubMed.gov – 8 May 2017
Abstract
Environmental factors have been implicated in the etiology of autism spectrum disorder (ASD); however, the role of heavy metals has not been fully defined. This study investigated whether blood levels of mercury, arsenic, cadmium, and lead of children with ASD significantly differ from those of age- and sex-matched controls. One hundred eighty unrelated children with ASD and 184 healthy controls were recruited. Data showed that the children with ASD had significantly (p < 0.001) higher levels of mercury and arsenic and a lower level of cadmium. The levels of lead did not differ significantly between the groups. The results of this study are consistent with numerous previous studies, supporting an important role for heavy metal exposure, particularly mercury, in the etiology of ASD. It is desirable to continue future research into the relationship between ASD and heavy metal exposure

Vaccine News – This is the Best Explanation of the Vaccine/Autism Connection I’ve Ever Heard!

The Only Vaccine Guide a New Parent Will Ever Need
BY J.B. HANDLEY
First, a disclaimer: I’m not a doctor, and the final decision about vaccinating your child should take place between you and your healthcare provider. I’m not giving you medical advice; I’m stating my opinion.
I am a dad. And, I write this without benefitting in anyway from what is said here. I have no book to peddle, no profits to protect, and there’s no doubt that writing this will result in some amount of hate directed in my general direction for challenging a popular narrative that vaccines are only safe and effective and should be administered the same way to all children without consideration for the unique biology of each and every child. So be it.
Do your own research. Understand the risks and benefits of everything you are putting into your child.
Find a healthcare provider who doesn’t believe “one size fits all” when it comes to vaccines

The Vaccine Studies That Have Never Been Done.
1. Study Proving the Existing Vaccine Schedule Is Safe – NEVER DONE
2. Study Proving Safety of Childhood Vaccines For Children – NEVER DONE
3. Study Proving Safety of Infant Vaccines For Infants – NEVER DONE
4. Study Proving Vaccines Safe for Pregnant Women – NEVER DONE
5. Study Proving Vaccines Safe For Unborn Fetus – NEVER DONE
6. Study Comparing the Health of Vaccinated vs Un-Vaccinated – NEVER DONE
7. Study to Prove Combining Several Vaccines at One Doctor’s Visit Is Safe – NEVER DONE
8. Study That Exposes Vaccinated People to Targeted Virus (to see if they get sick or not) – NEVER DONE
9. Study That Proves Vaccinated People Don’t Acquire the Targeted Disease – NEVER DONE
10. Study Proving Thimerosal (mercury) or Aluminum Are Safe to Inject Into Children – NEVER DONE
Read # 8 again and then read it again…….and then think about that.
These are the studies the average person assumes were already done decades ago and they have NEVER been done. If you’re not concerned, you’re not paying attention.
~ Chris Kirckof

Disturbing tape-recording of an immunologist having a laugh over the numerous and useless vaccines they inject for a child’s first year of life, in order to keep parents compliant and unquestioning of what is being done to their baby. Research is KEY and education is empowerment

Pro-Vaccine Immunologist Admits a Shocking Truth About Vaccines
For several years, until April of this year, I had been lecturing nationally to health professionals about the great vaccine hoax. Attending one such seminar was a board member of an association of health professionals, who invited me to speak on this subject at their national conference. I did, and had 90 minutes to present the most salient points from my 7-hour seminar. It caused quite a stir, and several clinicians thanked me for having the courage to speak the truth about this controversial subject.
Later that day, I sat on a panel of four experts to answer questions from conference attendees. Many of the questions were directed at the PhD immunologist on the panel, asking if the statements I had made in the morning presentation were true. To my surprise, the immunologist confirmed every assertion I had made.
The first was that it is pointless to administer drugs intended to stimulate antibody production to babies who are too young to produce antibodies. Infants in their first year mostly depend on generalized, non-specific immunity, including (hopefully) immunoglobulins from breast milk, to protect their young bodies from infection. They do not produce antibodies of their own until about age one. Despite this basic fact, the medical establishment insists administering a total of 19 shots, containing 24 vaccines, to infants on the 2, 4 and 6 month pediatric visits (Source: cdc.gov). Somehow, the basic facts of human physiology and development do not apply to vaccines.
You can listen to an audio file of an exchange between an attendee and the immunologist about this question. She declined to be identified in my presentations, including this post, perhaps because she knows that anyone who speaks the truth about vaccines is savaged by the medical establishment and their compliant lapdogs in the mainstream media. It is professional suicide for anyone in conventional medicine to question the unquestionable (yet unproven) assumptions about vaccines: that they are effective, safe and necessary. I have stopped lecturing publicly on this subject for the same reason, because the attacks in recent years have become particularly vicious; and because my main message in my teachings is about personal responsibility, innate wholeness and opening to the largeness of who we are, not just vaccines.

Study – A modified self-controlled case series method to examine association between multidose vaccinations and death
Abstract
The self-controlled case series method (SCCS) was developed to analyze the association between a time-varying exposure and an outcome event. We consider penta- or hexavalent vaccination as the exposure and unexplained sudden unexpected death (uSUD) as the event. The special situation of multiple exposures and a terminal event requires adaptation of the standard SCCS method. This paper proposes a new adaptation, in which observation periods are truncated according to the vaccination schedule. The new method exploits known minimum spacings between successive vaccine doses. Its advantage is that it is very much simpler to apply than the method for censored, perturbed or curtailed post-event exposures recently introduced. This paper presents a comparison of these two SCCS methods by simulation studies and an application to a real data set. In the simulation studies, the age distribution and the assumed vaccination schedule were based on real data. Only small differences between the two SCCS methods were observed, although 50 per cent of cases could not be included in the analysis with the SCCS method with truncated observation periods. By means of a study including 300 uSUD, a 16-fold risk increase after the 4th dose could be detected with a power of at least 90 per cent. A general 2-fold risk increase after vaccination could be detected with a power of 80 per cent. Reanalysis of data from cases of the German case-control study on sudden infant death (GeSID) resulted in slightly higher point estimates using the SCCS methods than the odds ratio obtained by the case-control analysis.

The Top 10 Reasons To Never Take A Vaccine
There are many, many good reasons to never take a vaccine. Whether you want to protect yourself against carcinogenic hidden ingredients, disallow toxic adjuvants into your body, defend your immune system against a chemical onslaught or refuse to be part of any sinister schemes of sterilization-depopulation agenda, this information is vitally important.
More and more, we are learning the truth about vaccines, what they are really composed of and what they really do to the human body – and the more we learn about them, the more we see just how dangerous and harmful they are. Whatever they may have been or could be, as it stands, they are a weapon of medical destruction that makes billions of dollars for the Rockefeller Medicine Big Pharma cartel. Here is my list of the top 10 reasons for an ordinary person to never take a vaccine, unless they were in a life-threatening situation where somehow the benefit outweighed the risk.

Reason #1 to Never Take a Vaccine: Toxic Ingredients – Formaldehyde, MSG, Antibiotics, GMOs, Polysorbate, Mercury, Squalene and More
Reason #2 to Never Take a Vaccine: Toxic Adjuvants – Aluminum
Reason #3 to Never Take a Vaccine: Hidden Ingredients – Immunity-Destroying Nagalese
Reason #4 to Never Take a Vaccine: Injection of Human and Animal Cells
Reason #5 to Never Take a Vaccine: Blood Sludge, Hypoxia, Ischemia and Localized “Strokes” in Your Body
Reason #6 to Never Take a Vaccine: The Herd Immunity Myth Busted
Reason #7 to Never Take a Vaccine: Viral Shedding
Reason #8 to Never Take a Vaccine: Possible Side Effects of Paralysis and Death
Reason #9 to Never Take a Vaccine: Insufficient Legal Recourse
Reason #10 to Never Take a Vaccine: The Vaccine-Sterilization-Depopulation Connection

Remember that Bill Gates himself, point man for the NWO agenda, has slipped up and admitted there is a vaccine-depopulation link on at least 2 occasions:

“… if we do a really great job on new vaccines … we could lower that (i.e. population growth) perhaps by 10-15% …”
“… the benefits (of vaccines) are there in terms of reducing sickness, reducing population growth …”

WEM NÜTZT DAS IMPFEN?
Zeit für einen Shitstorm gegen die Impfstoffhersteller! In deren Prospekten stimmt kein einziger Satz, schwere Nebenwirkungen werden mit Hilfe einer Armada von Lobbyisten verschwiegen, damit der Rubel rollt. Es ist Zeit, den Verletzungen an Körper, Geist und Seele, die von Impfungen verursacht werden, ein Ende zu bereiten!
Impfungen haben keine einzige Seuche ausgerottet – das zeigen Statistiken des Bundes. Jede Seuche war aufgrund des wachsenden Wohlstands nach dem 2. WK schon so gut wie verschwunden, BEVOR die entsprechende Impfung auf den Markt kam!
Schluss mit den Lügen der Pharma-Industrie und staatlich organisierten Subventionen wie bei den “Schweinegrippe-Impfstoffen”!
Konkret sind im ersten Lebensjahr von der Lobbygruppe “StIKo” empfohlen:4 x 6-fach-Impfung, 4 x Pneumokokken, 1 x MMRV (4-fach), dazu kommen optionale Impfungen wie gegen “Rotaviren” oder Influenza, die viele Ärzte zusätzlich verimpfen. Macht maximal 34 Impfungen im ersten Lebensjahr. Und im 2. Lebensjahr wird dann munter weitergeimpft…
FÜR EINE FREIE ZUKUNFT GESUNDER MENSCHEN! IMPFEN MUSS FREIWILLIG BLEIBEN!
http://www.facebook.com/FIEGZ
http://www.freie-impfentscheidung.blogspot.com

Study – What is regressive autism and why does it occur? Is it the consequence of multi-systemic dysfunction affecting the elimination of heavy metals and the ability to regulate neural temperature?
Abstract
There is a compelling argument that the occurrence of regressive autism is attributable to genetic and chromosomal abnormalities, arising from the overuse of vaccines, which subsequently affects the stability and function of the autonomic nervous system and physiological systems. That sense perception is linked to the autonomic nervous system and the function of the physiological systems enables us to examine the significance of autistic symptoms from a systemic perspective. Failure of the excretory system influences elimination of heavy metals and facilitates their accumulation and subsequent manifestation as neurotoxins: the long-term consequences of which would lead to neurodegeneration, cognitive and developmental problems. It may also influence regulation of neural hyperthermia. This article explores the issues and concludes that sensory dysfunction and systemic failure, manifested as autism, is the inevitable consequence arising from subtle DNA alteration and consequently from the overuse of vaccines.

Study – A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States
Abstract
Background
Autism spectrum disorder (ASD) is defined by standardized criteria of qualitative impairments in social interaction, qualitative impairments in communication, and restricted and stereotyped patterns of behavior, interests, and activities. A significant number of children diagnosed with ASD suffer a loss of previously-acquired skills, which is suggestive of neurodegeneration or a type of progressive encephalopathy with an etiological pathogenic basis occurring after birth. To date, the etiology of ASD remains under debate, however, many studies suggest toxicity, especially from mercury (Hg), in individuals diagnosed with an ASD. The present study evaluated concerns about the toxic effects of organic-Hg exposure from Thimerosal (49.55% Hg by weight) in childhood vaccines by conducting a two-phased (hypothesis generating/hypothesis testing) study with documented exposure to varying levels of Thimerosal from vaccinations.
Methods
A hypothesis generating cohort study was undertaken to evaluate the relationship between exposure to organic-Hg from a Thimerosal-containing Diphtheria-Tetanus-acellular-Pertussis (DTaP) vaccine in comparison to a Thimerosal-free DTaP vaccine administered, from 1998 through 2000, for the risk of ASD as reported in the Vaccine Adverse Event Reporting System (VAERS) database (phase I). A hypothesis testing case–control study was undertaken to evaluate the relationship between organic-Hg exposure from Thimerosal-containing hepatitis B vaccines administered at specific intervals in the first six months of life among cases diagnosed with an ASD and controls born between 1991 through 1999 in the Vaccine Safety Datalink (VSD) database (phase II).
Results
In phase I, it was observed that there was a significantly increased risk ratio for the incidence of ASD reported following the Thimerosal-containing DTaP vaccine in comparison to the Thimerosal-free DTaP vaccine. In phase II, it was observed that cases diagnosed with an ASD were significantly more likely than controls to receive increased organic-Hg from Thimerosal-containing hepatitis B vaccine administered within the first, second, and sixth month of life.
Conclusions
Routine childhood vaccination is an important public health tool to reduce the morbidity and mortality associated with infectious diseases, but the present study provides new epidemiological evidence supporting an association between increasing organic-Hg exposure from Thimerosal-containing childhood vaccines and the subsequent risk of an ASD diagnosis.

#VaxXed #medical #Oregon
Dr Paul Thomas interview with Polly Tommey
June 17, 2017

The Shift Episode 8: Del Bigtree
Join host Doug McKenty as he discusses the controversial movie Vaxxed with producer Del Bigtree. Listen in as the conversation includes the real story behind Dr. Andrew Wakefield’s study of the MMR vaccine that started it all, the realization that regulatory agencies have been corrupted at the highest levels, as well as the real reasons behind the mainstream media’s complicity in covering up the actual science behind vaccine safety. Find out more about it at http://www.vaxxedthemovie.com, and as always help out at http://www.patreon.com/theshift or visit http://www.theshiftnow.com for more information about making The Shift.

Billy D Live with Del Bigtree
Watch Billy D and Del Bigtree talk about vaccines
Go to https://caljamnetwork.org/ to watch Jeremy’s Stretch video series.

Follow Billy D. on
facebook – https://www.facebook.com/billy.demoss1/
website – http://www.californiajam.org/

Vaccine’s Safety: A Crime Against Humanity
Dr. Sherri J Tenpenny warns about the perils of vaccination

This is the Best Explanation of the Vaccine/Autism Connection I’ve Ever Heard!
Dr. Stephanie Seneff discusses the potential connection between vaccines and autism. It’s a hotly-debated topic. Here she gets specific into what ingredient in the vaccine may be linked to autism and other conditions. Find out what her research has found. You may think differently after watching this!

Trace Amounts: Ethyl Mercury | Educational Documentary
Has Ethyl Mercury Caused One of the Worst Health Crises in American History? During the past 20 years, the frequency of autism occurring in children has .
This video shares facts about the devastating mercury based preservative, thimerosal, used in vaccines. .
For this EP of Zero Doubt Zone, host Dane Sorenson, circles back to the subject of vaccines. On the heels of viewing the documentary, ‘Trace Amounts’, .
Courtesy of AAE tv Documentary filmmaker and researcher, Eric Gladen. Ethann and Eric discuss his new film “Trace Amounts”. They talk about the scientific .

Shots In The Dark: Silence on Vaccine
Following the increase in cases of autism and other immune disorders among some particularly vulnerable people, several recognized specialists are questioning the safety of large-scale vaccination. Despite the serious side effects, pharmaceutical companies, the medical profession and government authorities continue to bury their heads in the sand, refusing to see a serious problem. In Quebec, the United States and France, as in most industrialized countries, victims are almost without recourse despite the high toxicity of substances such as mercury and aluminum contained in vaccines. With this hard-hitting documentary, Lina B. Moreco highlights a very worrying public health problem.
Since they were introduced in the early 20th century, vaccines have been a tremendous medical and scientific success. Today perceived as a necessity, they are so familiar to us that their potential risks are rarely mentioned.
However, the stakes are significant. Based on recommendations of health agencies, North American children receive about 48 doses of 14 different vaccines before the age of 6 — double the amount prescribed 25 years earlier. Despite this extraordinary increase, few studies independent of the pharmaceutical industry have been conducted into their long-term side effects. This is a disturbing situation given the numerous toxins, including mercury and aluminum, contained in some commonly administered vaccines.
Several worried pediatricians and scientists are sounding the alarm. Some of the research underway indicates that vaccination is directly responsible for immune or neurological disorders among certain people genetically or neurologically predisposed to react badly to vaccine components. Cases of autism, multiple sclerosis, Guillain-Barré syndrome, macrophagic myofasciitis, encephalitis, paralysis and neuropathies indicate the seriousness of the situation.
Despite these findings, the pharmaceutical industry and government authorities deny there is a serious problem. Relying on perfunctory studies, some of which date back to the late 1920s, they reject out of hand any cause-and-effect relationship. Given the known fact that adding preservatives such as thimerosal (mercury) helps reduce production costs, the reaction of the pharmaceutical industry is at the very least puzzling. Preferring not to question a system that has proved its worth, a majority of the medical profession’s members reject any potential toxicity in vaccines.
http://films.nfb.ca/shots-in-the-dark/
FAIR USE NOTICE: These Videos may contain copyrighted (© ) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available to advance understanding of ecological, political, human rights, economic, democracy, scientific, moral, ethical, and social justice issues, etc. It is believed that this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior general interest in receiving similar information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode

Bought
The truth about vaccines and Big Pharma, and info on GMO foods

Se cere demisia ministrului Sănătăţii. Motivul – legea care prevede vaccinarea obligatorie
In nicio țară din Uniunea Europeană nu sunt obligatorii 8 vaccinuri!
In Germania, Austria, Olanda, Spania, Portugalia, Marea Britanie, Luxemburg, Suedia, Danemarca, Italia, Irlanda, Finlanda, Suedia, Croația, Cipru, Estonia și Lituania, părinții decid dacă &icirc;și vaccinează copiii!
Vaccinul este un medicament, dar poate fi și o armă biologică!
Peste 180.000 de copii vor fi obligați, in primul an de viață, să primească 26 de vaccinuri!
in cazul unui copil contraindicația definitivă la un vaccin sau mai multe se acordă numai la București de către GTCAV!
Pana la varsta de 6 ani un copil trebuie să primească 33 de vaccinuri!
Vaccinurile provoacă boli autoimune: un copil din patru suferă de o boală alergică, iar un copil din zece suferă de astm bronșic!
Asociația Pro Consumatori are o activitate de peste 27 de ani in domeniul apărării drepturilor și intereselor economice ale consumatorilor.